Skip navigation links
Peter Gulick, DO FACP, FIDSA, FACOI

Peter Gulick, DO FACP, FIDSA, FACOI

Professor of Medicine

Take care of HIV/AIDS patients as well as Hepatitis C, B patients at 3 sites in Michigan

Get In Touch

Area of Expertise

Hepatitis C Hiv/Aids Hepatitis B

Biography

Peter Gulick is currently an associate professor of medicine at Michigan State University, College of Osteopathic Medicine, and serves as adjunct faculty in the College of Human Medicine and the College of Nursing.

He received training in two primary specialties: infectious diseases at the Cleveland Clinic Foundation and medical oncology at Roswell Park Memorial Institute.

Gulick is director of the MSU HIV/Hepatitis clinic where his primary area of interest is HIV therapy, as well as hepatitis ... B, hepatitis C and co-infection therapy.

In addition to teaching, Gulick has cared for HIV patients for 20 years and hepatitis C patients for 10 years.

He has served on the Lung Cancer Advisory Committee through the State of Michigan's Department of Community Health , as well as the HIV/AIDS Prevention and Intervention Section, the Michigan Cancer Consortium and the Region 1 Smallpox Planning Team.

Read More

Education

Cleveland Clinic Foundation: Infectious Diseases, | 1983

Roswell Park Memorial Institute: Medical Oncology, | 1981

Cleveland Clinic Foundation: Internal Medicine, | 1980

Detroit Osteopathic Hospital: Internship, | 1977

Midwestern University: D.O., | 1976

Michigan State University: M.D.,

University of Michigan,: M.A., Health Managements and Policy

Selected Press

Infectious disease expert praises vaccination rate

WKAR | 2021-03-11

With the number of people vaccinated against coronavirus growing daily, people in Michigan are starting to wonder about life after getting their shots. WKAR's Scott Pohl talks with Peter Gulick, an expert in infectious diseases at Michigan State University. Gulick is impressed with the pace of vaccinations. “There's a lot of resources, I think, to get people vaccinated. Now, it's not as restricted as it was before. As far as around the country, it depends on the state you're in and what requirements they have, and what issues they have, but I think that we still have a long way to go. I think we still have to really promote and push vaccines and try to get them implemented as effectively as possible.”

What does COVID-19 vaccine efficacy mean?

Verywell Health | 2021-02-16

Peter Gulick, associate professor of medicine at Michigan State University, tells Verywell that everyone should get the vaccine in order to decrease overall levels of the virus. “Just get vaccinated because the more people that get vaccinated, the closer we'll get to herd immunity,” Gulick says. Gulick explains that despite getting the vaccine, people may still transmit it to others. “Patients that get the vaccine may still be able to colonize," Gulick says. "They may have the virus up in their nose and it may not cause them disease where they feel symptoms." Because the disease might still be transmitted even after vaccination, Gulick recommends people continue wearing a mask, social distancing, and washing their hands regularly.

Who should get the Johnson & Johnson vaccine over the mRNA vaccines?

Live Science | 2021-02-15

While the Moderna and Pfizer two-shot regimens look, on paper, to be more efficacious, the Johnson & Johnson vaccine has an edge because it doesn't require a follow-up shot and it can be stored at ordinary refrigerator temperatures for months, said Peter Gulick, a professor of medicine and an infectious disease expert at Michigan State University College of Osteopathic Medicine. That could help with getting more people vaccinated especially those who may not come back for a second shot, as well as in locales where access is a problem, he said. The Johnson & Johnson shot's less stringent storage requirements could be an advantage in rural areas, Gulick said. "They can be put in a refrigerator and stored there, whereas Moderna, and definitely Pfizer, need much colder temperatures to keep their vaccine viable," Gulick told Live Science.

Arm pain after COVID-19 vaccine common

MedShadow | 2021-02-05

“The most common symptom patients are getting from these injections is pain. That's about 70% of the time,” says Peter Gulick, an associate professor of medicine at Michigan State University. He adds that his own arm was sore after he received the first shot of the Pfizer vaccine, but not after the second. Now, as more and more people are getting their shots, we're hearing details and personal stories, and a trend is emerging. Our vaccine side effect tracker has amassed more than 100 comments, many of which describe varying degrees of arm pain after the COVID-19 vaccine, along with redness, itching and swelling at the injection site.

Media Assets